Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease. [electronic resource]
Producer: 20040921Description: e25 p. digitalISSN:- 1097-6744
- Blood Platelets -- metabolism
- Coronary Disease -- blood
- Diabetes Complications
- Double-Blind Method
- Female
- Humans
- Insulin Resistance
- Male
- Middle Aged
- P-Selectin -- blood
- Platelet Activation -- drug effects
- Platelet Count
- Receptors, Cytoplasmic and Nuclear -- agonists
- Rosiglitazone
- Thiazolidinediones -- pharmacology
- Transcription Factors -- agonists
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.